Upgrade to SI Premium - Free Trial

Kymera Therapeutics (KYMR) PT Raised to $129 at Canaccord

June 26, 2026 7:37 AM
(Updated - June 26, 2026 8:15 AM EDT)

Canaccord analyst Edward Nash raised the price target on Kymera Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change